Igenica Biotherapeutics' Series C - II Round

Igenica Biotherapeutics raised a round of funding on January 28, 2014.

Igenica is focused on the discovery and development of antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. Igenica is the only biotherapeutic company that fully powers the ADC …

Articles about Igenica Biotherapeutics' Series C - II Round: